Initial experience with tadalafil in pediatric pulmonary arterial hypertension (Q33161066)

23 July 2017

title

Initial experience with tadalafil in pediatric pulmonary arterial hypertension (English)

1 reference

23 July 2017

main subject

arterial hypertension

1 reference

Shinichi Takatsuki

1

1 reference

23 July 2017

Michelle Calderbank

series ordinal

2

1 reference

23 July 2017

David Dunbar Ivy

series ordinal

3

1 reference

23 July 2017

publication date

9 March 2012

1 reference

23 July 2017

1 reference

23 July 2017

volume

33

1 reference

23 July 2017

issue

5

1 reference

23 July 2017

page(s)

683-688

1 reference

Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical Settings

23 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366091

Tadalafil for the treatment of pulmonary arterial hypertension.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366091

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366091

Sildenafil citrate therapy for pulmonary arterial hypertension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366091

A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366091

Beraprost therapy for pulmonary arterial hypertension

28 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0180-4

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0180-4

Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0180-4

Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0180-4

Outcomes in children with idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0180-4

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366091

A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension

31 October 2018

1 reference

12 December 2020

Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study

1 reference

12 December 2020

Pulmonary arterial hypertension

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension

1 reference

12 December 2020

10.1007/S00246-012-0180-4

Identifiers

DOI

1 reference

Dimensions Publication ID

23 July 2017

0 references

1 reference

23 July 2017

1 reference